Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

v3.24.3
Stockholders’ Equity (Details) - USD ($)
 3 Months Ended 4 Months Ended 6 Months Ended
May 30, 2024
Mar. 27, 2024
Oct. 06, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 12, 2024
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Stockholders’ Equity [Line Items]                  
Convertible preferred shares       45,000,000     45,000,000   45,000,000
Full settlement of accounts payable (in Dollars) $ 37,500     $ 154,158 $ 44,167 $ 183,644 $ 183,644 $ 44,167  
Price of per share (in Dollars per share) $ 1.79                
Shares of common stock valued (in Dollars) $ 67,200           $ 67,200  
Minimum [Member]                  
Stockholders’ Equity [Line Items]                  
Reverse split     1            
Price of per share (in Dollars per share)           $ 1.2      
Maximum [Member]                  
Stockholders’ Equity [Line Items]                  
Reverse split     15            
Price of per share (in Dollars per share)           $ 2.65      
Series A Convertible Preferred Stock [Member]                  
Stockholders’ Equity [Line Items]                  
Authorized shares       900,000     900,000   900,000
Authorized per share (in Dollars per share)       $ 0.001     $ 0.001   $ 0.001
Common Stock [Member]                  
Stockholders’ Equity [Line Items]                  
Stock issued during period, restricted shares   1,667     14,444   1,667 15,199  
Stock issued during period shares       73,306 10,070 94,711 94,711 10,070  
Full settlement of accounts payable (in Dollars)       $ 73 $ 10   $ 94 $ 10